(Q33917889)

30 July 2017

1 reference

title

Economic evaluation of parasitic diseases: a critique of the internal and external validity of published studies (English)

1 reference

30 July 2017

Walker D

1

1 reference

PubMed ID

10810015

30 July 2017

Fox-Rushby J

series ordinal

2

1 reference

30 July 2017

1 April 2000

1 reference

Tropical Medicine and International Health

30 July 2017

1 reference

30 July 2017

5

1 reference

30 July 2017

4

1 reference

30 July 2017

237-249

1 reference

Sensitivity analysis in economic evaluation: a review of published studies

30 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00546.X

Rebound mortality and the cost-effectiveness of malaria control: potential impact of increased mortality in late childhood following the introduction of insecticide treated nets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00546.X

Theoretical and empirical issues in benefit identification, measurement and valuation related to parasitic disease control in poor countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00546.X

Should governments subsidize the use of insecticide-impregnated mosquito nets in Africa? Implications of a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00546.X

The generalisability of pharmacoeconomic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00546.X

The economic evaluation of malaria control technologies: The case of Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00546.X

Is malaria control a priority? Evidence from Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00546.X

A critical review of priority setting in the health sector: the methodology of the 1993 World Development Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00546.X

Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00546.X

Five-hundred life-saving interventions and their cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00546.X

Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00546.X

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00546.X

10.1046/J.1365-3156.2000.00546.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10810015